Skip to content
TCR-T CELL THERAPY
OUR APPROACH
OUR SCIENCE
Manufacturing
PIPELINE
PATIENTS
ABOUT
MANAGEMENT TEAM
BOARD OF DIRECTORS
PARTNERSHIPS
SCIENTIFIC PUBLICATIONS
Houston
CONTACT
INVESTORS
INVESTORS HOME
PRESS RELEASES
STOCK PERFORMANCE
Stock Information
Historic Lookup
SEC FILINGS
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Board of Directors
Committees and Charters
ANALYST COVERAGE
INVESTOR FAQS
Menu
TCR-T CELL THERAPY
OUR APPROACH
OUR SCIENCE
Manufacturing
PIPELINE
PATIENTS
ABOUT
MANAGEMENT TEAM
BOARD OF DIRECTORS
PARTNERSHIPS
SCIENTIFIC PUBLICATIONS
Houston
CONTACT
INVESTORS
INVESTORS HOME
PRESS RELEASES
STOCK PERFORMANCE
Stock Information
Historic Lookup
SEC FILINGS
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
Board of Directors
Committees and Charters
ANALYST COVERAGE
INVESTOR FAQS
Pipeline
An Advanced Platform Targeting Solid Tumors
Focused Pipeline of Innovation in Cell Therapy for Oncology
